GPT and metabolic dysfunction-associated steatotic liver disease: Although the serum levels of ALT/AST and histological inflammation score (NAFLD activity score) were significantly improved in the liver of patients with MASH, the degree of steatosis and fibrosis stage were not improved (Figure 1 and Supplemental Table S1, http://links.lww.com/HC9/A845).